These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25153726)

  • 1. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells.
    Li XT; Ju RJ; Li XY; Zeng F; Shi JF; Liu L; Zhang CX; Sun MG; Lou JN; Lu WL
    Oncotarget; 2014 Aug; 5(15):6497-511. PubMed ID: 25153726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
    Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
    Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Functional Targeting Daunorubicin Liposomes Used for Eliminating Brain Glioma and Glioma Stem Cells.
    Zhao WY; Zhang CX; Liu L; Mu LM; Zeng F; Ju RJ; Xie HJ; Yan Y; Zhao Y; Lu WL
    J Biomed Nanotechnol; 2016 Jul; 12(7):1404-420. PubMed ID: 29336535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
    Liu S; Zhang SM; Ju RJ; Xiao Y; Wang X; Song XL; Gu LY; Cheng L; Li XT; Chen GR
    Eur J Pharm Sci; 2017 Aug; 106():185-197. PubMed ID: 28583810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells.
    Zhang L; Yao HJ; Yu Y; Zhang Y; Li RJ; Ju RJ; Wang XX; Sun MG; Shi JF; Lu WL
    Biomaterials; 2012 Jan; 33(2):565-82. PubMed ID: 21983136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
    J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma.
    Xiao Y; Cheng L; Xie HJ; Ju RJ; Wang X; Fu M; Liu JJ; Li XT
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S524-S537. PubMed ID: 30299160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma.
    Xie HJ; Zhan-Dui N; Zhao J; Er-Bu AGA; Zhen P; ZhuoMa D; Sang T
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):596-605. PubMed ID: 34514904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
    Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
    Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
    Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL
    Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas.
    Kong D; Hong W; Yu M; Li Y; Zheng Y; Ying X
    Int J Nanomedicine; 2022; 17():1087-1110. PubMed ID: 35313461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma.
    Li XT; Tang W; Xie HJ; Liu S; Song XL; Xiao Y; Wang X; Cheng L; Chen GR
    J Liposome Res; 2019 Mar; 29(1):21-34. PubMed ID: 29166813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer.
    Liu S; Song XL; Wang YH; Wang XM; Xiao Y; Wang X; Cheng L; Li XT
    J Drug Target; 2017 Jul; 25(6):541-553. PubMed ID: 28277825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.
    Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF
    J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
    Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
    Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid vesicles containing transferrin receptor binding peptide TfR-T
    Mu LM; Bu YZ; Liu L; Xie HJ; Ju RJ; Wu JS; Zeng F; Zhao Y; Zhang JY; Lu WL
    Sci Rep; 2017 Jun; 7(1):3487. PubMed ID: 28615716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma.
    Liu Y; Mei L; Yu Q; Xu C; Qiu Y; Yang Y; Shi K; Zhang Q; Gao H; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2015 Aug; 7(30):16792-801. PubMed ID: 26173814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.